Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
USP Technologies is a leading provider of peroxygen-based technologies and full-service chemical treatment programs for municipal and industrial water and wastewater treatment. Formerly known as US Peroxide, the company specializes in the application of hydrogen peroxide, peracetic acid, and other oxidants to solve complex treatment challenges such as odor control, phosphorus removal, and disinfection. While primarily an environmental services firm, USP Technologies serves the pharmaceutical and life sciences industries by providing high-purity water treatment and process water solutions. The company was acquired by Danaher in 2011 and subsequently became part of Veralto following its spin-off in 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on USP Technologies.